The strategic collaborations born out of the efforts to help address the COVID-19 pandemic have offered a wealth of insight into how the biopharma industry will continue to change in the years to come. Companies across the supply chain—from raw materials and technology suppliers to biomanufacturers—view collaboration as a critical strategy to advancing biologics research, scale-up and manufacturing for all biologics development.
Register and join Avantor and C&EN for a webinar featuring Avantor subject matter experts and guest industry speakers, discussing the benefits of partnership and collaboration.
This webinar event, hosted by C&EN, took place, October 27, 2021